Campbell Norm R C, Correa-Rotter Ricardo, Cappuccio Francesco P, Webster Jacqui, Lackland Daniel T, Neal Bruce, MacGregor Graham A
Departments of Medicine, Community Health Sciences and of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada.
J Clin Hypertens (Greenwich). 2015 Apr;17(4):247-51. doi: 10.1111/jch.12442. Epub 2014 Nov 21.
There is considerable confusion about what ranges of dietary salt(a) could be considered low, normal, or high and also what ranges of reduction in dietary salt are small or large. The World Hypertension League with other organizations involved in dietary salt reduction have proposed a standardized nomenclature based on normal ancestral levels of salt intake and also on ranges of reduction in salt intake in clinical and population interventions. Low daily salt (sodium) intake where harm due to deficiency would be expected to occur is recommended to remain undefined because of inadequate research but likely <0.25 g (100 mg), normal (physiological) intake <2.5 g (1000 mg), recommended intake <5.0 g (2000 mg), high ≥5.0 g (2000 mg), very high >10 to 15 g (4000-6000 mg), and extremely high >15 g (6000 mg). Reductions in daily salt (sodium) intake are recommended to be called small if <2.5 g (1000 mg), moderate if 2.5 to 5.0 g (1000-2000 mg) and large if >5.0 g (2000 mg). Use of this nomenclature is likely to result in less confusion about salt intake and interventions to reduce dietary sodium.
对于何种膳食盐(a)摄入量范围可被视为低、正常或高,以及何种膳食盐减少量范围算小或大,存在相当大的混淆。世界高血压联盟与其他参与膳食盐减少工作的组织,已基于正常的祖先盐摄入量水平以及临床和人群干预中盐摄入量的减少范围,提出了一种标准化的命名法。由于研究不足,预计会因缺乏盐而造成危害的低每日盐(钠)摄入量范围建议暂不定义,但可能<0.25克(100毫克),正常(生理)摄入量<2.5克(1000毫克),推荐摄入量<5.0克(2000毫克),高摄入量≥5.0克(2000毫克),非常高摄入量>10至15克(4000 - 6000毫克),以及极高摄入量>15克(6000毫克)。如果每日盐(钠)摄入量减少量<2.5克(1000毫克),建议称为小幅度减少;如果是2.5至5.0克(1000 - 2000毫克),称为中等幅度减少;如果>5.0克(2000毫克),则称为大幅度减少。使用这种命名法可能会减少关于盐摄入量和减少膳食钠干预措施的混淆。